Status:
WITHDRAWN
Effects of Travoprost on Neovascular Glaucoma
Lead Sponsor:
Federal University of São Paulo
Conditions:
Neovascular Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucom...
Eligibility Criteria
Inclusion
- Neovascular glaucoma of known cause
- Older than 18 years
- Previously submitted to retinal photocoagulation
- Under medical treatment to glaucoma
Exclusion
- Need of antiglaucomatous surgery
- Previous ocular surgery in the last 6 months
- Pregnancy
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00441181
Start Date
January 1 2008
End Date
December 1 2008
Last Update
June 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of São Paulo
São Paulo, São Paulo, Brazil, 04023-900